BIND Therapeutics Initiates Voluntary Chapter 11 Bankruptcy Protection Proceeding
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Stifel Downgrades BIND Therapeutics (BIND) to Hold Following Chapter 11
May 2, 2016 1:12 PM EDTStifel downgraded BIND Therapeutics (NASDAQ: BIND) from Buy to Hold following Chapter 11 filing.
For an analyst ratings summary and ratings history on BIND Therapeutics click here. For more ratings news on BIND Therapeutics click here.
Shares of BIND Therapeutics closed at $1.45 yesterday.
... MoreBIND Therapeutics (BIND) Announces Receipt of Notice of Default
May 2, 2016 6:28 AM EDTBIND Therapeutics (NASDAQ: BIND) disclosed the following on Monday:
Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
On April 26, 2016, the Company received a notice (the Notice) from Hercules Technology III, L.P. (Hercules) asserting that an event of default had occurred under the Companys amended and restated credit facility (as amended, the Credit Facility) with Hercules as lender. Pursuant to the Credit Facility, Hercules extended the... More
